Paper6797571
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
Smith IE and 10 others. Br Med J (Clin Res Ed), 1981. Cited by 156 papers, by iCite.
Cite this record
ConductScience Library. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Papers, record 6797571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6797571
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglutethimide | Major topic |
| Breast Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Adult | |
| Aged | |
| Bone Neoplasms | |
| Clinical Trials as Topic | |
| Drug Resistance | |
| Female | |
| Humans | |
| Male | |
| Menopause | |
| Middle Aged | |
| Random Allocation |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4292247 | Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. | J Clin Endocrinol Metab | 1967 | https://conductscience.org/library/papers/4292247 | PubMed |
| 2 | 856236 | Assessment of response to therapy in advanced breast cancer. | Br J Cancer | 1977 | https://conductscience.org/library/papers/856236 | PubMed |
| 3 | 6249490 | The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast. | Cancer | 1980 | https://conductscience.org/library/papers/6249490 | PubMed |
| 4 | 365330 | Tamoxifen in advanced breast cancer. | Cancer Treat Rev | 1978 | https://conductscience.org/library/papers/365330 | PubMed |
| 5 | 446416 | Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide. | Endocrinology | 1979 | https://conductscience.org/library/papers/446416 | PubMed |
| 6 | 80576 | Aminoglutethimide in treatment of metastatic breast carcinoma. | Lancet | 1978 | https://conductscience.org/library/papers/80576 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39821038 | Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/39821038 | PubMed |
| 38188305 | Aromatase inhibitors: the journey from the state of the art to clinical open questions. | Front Oncol | 2023 | https://conductscience.org/library/papers/38188305 | PubMed |
| 34801042 | Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study. | Radiat Oncol | 2021 | https://conductscience.org/library/papers/34801042 | PubMed |
| 26969590 | The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer. | Horm Cancer | 2016 | https://conductscience.org/library/papers/26969590 | PubMed |
| 22317766 | The sequential use of endocrine treatment for advanced breast cancer: where are we? | Ann Oncol | 2012 | https://conductscience.org/library/papers/22317766 | PubMed |
| 20616198 | The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum. | Ann Oncol | 2011 | https://conductscience.org/library/papers/20616198 | PubMed |
| 17973095 | Aromatase inhibitors: past, present and future in breast cancer therapy. | Med Oncol | 2008 | https://conductscience.org/library/papers/17973095 | PubMed |
| 17333340 | Letrozole in advanced breast cancer: the PO25 trial. | Breast Cancer Res Treat | 2007 | https://conductscience.org/library/papers/17333340 | PubMed |
| 12038879 | Aromatase inhibitors and inactivators for breast cancer therapy. | Drugs Aging | 2002 | https://conductscience.org/library/papers/12038879 | PubMed |
| 10146895 | Systemic therapy in breast cancer: efficacy and cost utility. | Pharmacoeconomics | 1994 | https://conductscience.org/library/papers/10146895 | PubMed |
| 9279502 | Breast cancer therapies in development. A review of their pharmacology and clinical potential. | Drugs | 1997 | https://conductscience.org/library/papers/9279502 | PubMed |
| 8595151 | Aromatase inhibitors--where are we now? | Br J Cancer | 1996 | https://conductscience.org/library/papers/8595151 | PubMed |
| 8554983 | Oestrogen receptor: a stable phenotype in breast cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8554983 | PubMed |
| 8477145 | Postmenopausal breast cancer. Drug therapy in the 1990s. | Drugs Aging | 1993 | https://conductscience.org/library/papers/8477145 | PubMed |
| 8260359 | cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8260359 | PubMed |
| 7981453 | The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7981453 | PubMed |
| 7949205 | First generation aromatase inhibitors--aminoglutethimide and testololactone. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7949205 | PubMed |
| 7797604 | Formestane: an effective first-line endocrine treatment for advanced breast cancer. | J Cancer Res Clin Oncol | 1995 | https://conductscience.org/library/papers/7797604 | PubMed |
| 6871483 | Aminoglutethimide treatment in advanced breast cancer: an efficient therapy as a late endocrine alternative in a sequential therapeutic approach. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6871483 | PubMed |
| 6861259 | Trilostane in the treatment of advanced breast cancer. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6861259 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6797571
GET https://conductscience.org/api/papers/v1/6797571/cited_by?page=2